Allston, Mass.
Cambridge-based Genzyme Corp. is adding two bioreactors to its $200-million, 180,000-sf Allston Landing facility. Expanding its biomanufacturing capacity, the plant will total six 2,000-liter bioreactors with the $30-million addition of the two new bioreactors, which should be operational by mid-2003.
